Agomelatine SPC

The Summary of Product Characteristics for agomelatine (Valdoxan®) is now available via the electronic Medicines Compendium (eMC).

As previously discussed, agomelatine is a new class of antidepressant. The SPC gives more details for this drug including known side effects, precautions and interactions.

Action: Clinicians who are considering using this new drug would be wise to review the SPC before starting a treatment.

Email Delicious Digg Facebook Google+ reddit StumbleUpon Twitter
« »

No Comments yet »

RSS feed for comments on this post. TrackBack URI

Leave a comment





XHTML: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS Feed for New Entries.
Akismet has protected Prescribing Advice for GPs from 378,243 spam comments.